New York, NY, United States of America

Seongho Ryu

This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seongho Ryu. Retrieved from https://idiyas.com/inventor/seongho-ryu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seongho Ryu: Innovator in Cancer Research

Introduction: Seongho Ryu is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms that inhibit the migration of cancer cells. His work is vital in the ongoing battle against cancer, aiming to improve treatment outcomes for patients.

Latest Patents: Seongho Ryu holds 1 patent related to his research. His patent focuses on the role of microRNA-708 in reducing the migration and metastasis of cancer cells. This innovative approach has the potential to lead to new therapeutic strategies in cancer treatment.

Career Highlights: Ryu is affiliated with Cornell University, where he conducts his research. His work at this esteemed institution allows him to collaborate with other leading scientists and contribute to groundbreaking discoveries in the field of oncology.

Collaborations: Seongho Ryu works alongside his coworker, Vivek Mittal, who is also involved in cancer research. Their collaboration enhances the research efforts at Cornell University and fosters an environment of innovation and discovery.

Conclusion: Seongho Ryu's contributions to cancer research through his innovative patent and collaboration with esteemed colleagues highlight his commitment to advancing medical science. His work is a testament to the importance of research in finding effective treatments for cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…